# IGNITE (Impact of Glucose moNitoring and nutrItion on Time in rangE)

Study · id `cardio:ct-nct05516797` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05516797](<https://clinicaltrials.gov/study/NCT05516797>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05516797

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 178 participants.

## Technical summary

Registry record NCT05516797. Randomized; no masking; primary purpose treatment. Start 2022-09-22 (actual); primary completion 2024-03-01 (actual). Results posted on 2025-03-26.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 178 participants (enrolled count; ClinicalTrials.gov record NCT05516797, source copy `cardio:ctgov-nct05516797-2025-03-26`, retrieved 2026-10-26)
- Started: 2022-09-22 (actual) (ClinicalTrials.gov record NCT05516797, source copy `cardio:ctgov-nct05516797-2025-03-26`, retrieved 2026-10-26)
- Primary completion: 2024-03-01 (actual) (ClinicalTrials.gov record NCT05516797, source copy `cardio:ctgov-nct05516797-2025-03-26`, retrieved 2026-10-26)
- Completion: 2024-03-01 (actual) (ClinicalTrials.gov record NCT05516797, source copy `cardio:ctgov-nct05516797-2025-03-26`, retrieved 2026-10-26)
- Results first posted: 2025-03-26 (ClinicalTrials.gov record NCT05516797, source copy `cardio:ctgov-nct05516797-2025-03-26`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT05516797, source copy `cardio:ctgov-nct05516797-2025-03-26`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05516797-2025-03-26`, retrieved 2026-10-26)

## The registry's words

- Brief title: IGNITE (Impact of Glucose moNitoring and nutrItion on Time in rangE)
- Acronym: IGNITE
- Condition: Type 2 Diabetes
- Intervention (Device): Continuous Glucose Monitoring (CGM)
- Lead sponsor: HealthPartners Institute
- Lead sponsor class: OTHER
- Collaborator: Virta Health
- Collaborator class: INDUSTRY
- Collaborator: Abbott Diabetes Care
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as a collaborator: Abbott Diabetes Care (`cardio:org-abbott-diabetes-care`)

## Provenance

Content hash: 4db7839a03916cd1460ab4c9ffc65522fad390332bb46c17b44042c4f1b81c4c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
